Transdermal Testosterone for Prostate Cancer
This trial is testing a possible new treatment for prostate cancer that could be more effective and have fewer side effects than current options.
- Castration-resistant Prostate Cancer
- Prostate Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Am I qualified to participate in this experiment?
"This clinical trial is recruiting participants with [prostate cancer](https://www.withpower.com/clinical-trials/prostate-cancer), aged 18 and over. The requisite criteria that must be met include: willingness to commit to the study's duration; a 6-week gap between stopping first-generation anti-androgens and randomization; worst pain in last 24 hours rated at 4 or below on a 0 to 10 scale; no daily use of narcotics for treating cancer-related pain (assessment during screening window to be documented); male gender; age 18 years old or older."
How many participants are conducting this research study?
"This clinical trial has halted participant recruitment for the time being. Initially published on January 18th 2019, this study was last amended on May 12th 2022. As an alternative, there are a total of 1324 trials recruiting prostate cancer patients and 126 studies in need of volunteers to test Transdermal Testosterone."
Could you elucidate other research endeavors that have explored Transdermal Testosterone?
"Currently, 126 clinical trials for transdermal testosterone are ongoing and 35 of these studies have reached their third phase. The majority of the investigations are located in Germantown, Tennessee yet a total of 5863 sites nationwide feature this medication trial."
Does this research endeavor currently require any new participants?
"Unfortunately, this medical trial is not currently open to recruitment. It was first advertised on January 18th 2019 and the latest update occurred on May 12th 2022. However, there are 1,324 trials recruiting for prostate cancer treatment and 126 studies searching for participants with Transdermal Testosterone issues."
Does this research involve minors under the age of 20?
"This study is currently seeking patients that are of legal age (18+) and under the century mark."
In what cases is Transdermal Testosterone typically administered?
"Sufferers of hypogonadotropic hypogonadism, post-menopausal women with 1 to 5 years since last period and orchidectomy can all benefit from the use of Transdermal Testosterone."